← All organizations
Highest phase reached
Phase 2
First clinical trial
May 1, 2011Last known activity
Apr 13, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 5 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT05243290Lead sponsorN/AApr 13, 2022
- NCT05243290Overall official - principal investigatorN/AApr 13, 2022
- NCT05252949Lead sponsorN/AJun 10, 2021
- NCT05252949Overall official - principal investigatorN/AJun 10, 2021
- NCT03974399Overall official - principal investigatorN/AMay 30, 2019
- NCT03974399Lead sponsorN/AMay 30, 2019
- NCT01669876Overall official - principal investigatorPhase 2Aug 1, 2012
- NCT01669876CollaboratorPhase 2Aug 1, 2012
- NCT01607619Lead sponsorN/AMay 1, 2011
Details
- Last known activity
- Apr 13, 2022